Immunoglobulin superfamily of proteins, CTLA-4 and PD-1, may generate treatments for RA, SLE
Search results for: cancer
2014 ACR/ARHP Annual Meeting: Regulatory T Cells
Rheumatology experts explore ways Treg cells contribute to autoimmune diseases, RA
The ACR Recommends Cautious Approach as Biosimilars Enter U.S. Market
With the U.S. FDA’s first approval of a biosimilar drug earlier this month, rheumatologists stress the need to ensure safety, efficacy of such drugs in treating rheumatic diseases
Certolizumab Pegol Drug Studies Find No New Safety Issues
Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information
Skin Disease in Rheumatology Patients Should Prompt Collaboration with Dermatologists
Patients with conditions that don’t resolve with topical steroids are signal for referral
UNC’s Thurston Arthritis Research Center in the Spotlight
Approachability, collaboration foster excellence in this basic science, clinical and epidemiological research program
2014 ACR/ARHP Annual Meeting: Lupus Nephritis
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
Biomarkers in Rheumatoid Arthritis Remain Elusive
Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient
The Rheumatologist as Detective
A case of difficult-to-diagnose Whipple’s disease
2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News
Plus, hydrocodone combination products and brodalumab
- « Previous Page
- 1
- …
- 65
- 66
- 67
- 68
- 69
- …
- 86
- Next Page »